# Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

> **NCT06284434** · PHASE3 · RECRUITING · sponsor: **Kerry O'Rourke** · enrollment: 60 (estimated)

## Conditions studied

- Cleft Lip and Palate

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Bupivacain
- **DRUG:** Epinephrine

## Key facts

- **NCT ID:** NCT06284434
- **Lead sponsor:** Kerry O'Rourke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-24
- **Primary completion:** 2026-04-24
- **Final completion:** 2026-04-24
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06284434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06284434, "Liposomal Bupivacaine Use in Alveolar Bone Graft Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06284434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*